- $211.55bn
- $207.44bn
- $64.11bn
- 92
- 29
- 79
- 73
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 43,215 | 44,327 | 50,533 | 61,594 | 64,112 |
Cost of Revenue | |||||
Gross Profit | 13,315 | 13,976 | 16,364 | 19,702 | 20,732 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 36,910 | 37,813 | 42,912 | 52,323 | 55,302 |
Operating Profit | 6,305 | 6,514 | 7,622 | 9,271 | 8,810 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6,252 | 6,774 | 7,761 | 9,196 | 9,139 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4,846 | 5,185 | 5,991 | 6,989 | 7,004 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 4,779 | 5,108 | 5,907 | 6,877 | 6,872 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 4,786 | 5,114 | 5,913 | 6,885 | 6,879 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 7.36 | 7.89 | 9.16 | 10.8 | 12 |
Dividends per Share |